[Federal Register Volume 69, Number 73 (Thursday, April 15, 2004)]
[Notices]
[Pages 20023-20024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-8494]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting; Interagency Autism Coordinating Committee

    The National Institutes of Health (NIH) hereby announces a meeting 
of the Interagency Autism Coordinating Committee (IACC) to be held on 
May 11, 2004, on the NIH campus in Bethesda, Maryland.
    The Children's Health Act of 2000 (Pub. L. 106-310), Title I, 
Section 104, mandated the establishment of an Interagency Autism 
Coordinating Committee (IACC) to coordinate autism research and other 
efforts within the Department of Health and Human Services (DHHS). In 
April 2001, Secretary Tommy Thompson delegated the authority to 
establish the IACC to the NIH. The National Institute of Mental Health 
(NIMH) at the NIH has been designated the lead for this activity.
    The IACC meeting will be open to the public, with attendance 
limited to space available. Individuals who plan to attend and need 
special assistance, such

[[Page 20024]]

as sign language interpretation or other reasonable accommodations, 
should notify the contact person listed below in advance of the 
meeting.
    Name of Committee: Interagency Autism Coordinating Committee.
    Date: May 11, 2004.
    Time: 9 a.m.-4:30 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, Building 31, Conference Room 
10 (6th floor), 31 Center Drive, Bethesda, Maryland 20892.
    Contact Person: Ann Wagner, Ph.D., Division of Services and 
Intervention Research, National Institute of Mental Health, NIH, 6001 
Executive Boulevard, Room 7142, MSC 9633, Bethesda, Maryland 20892, e-
mail: [email protected], Phone: (301) 443-4283.
    Any member of the public interested in presenting oral comments to 
the committee may notify the contact person listed on this notice at 
least 5 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. Presentations may be limited to 5 minutes; both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding his/her statement to the contact person listed 
on this notice. The statement should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person.
    Information about the meeting and registration forms are also 
available on-line on the NIMH homepage at http://www.nimh.nih.gov/autismiacc/index.cfm.

    Dated: April 7, 2004.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 04-8494 Filed 4-14-04; 8:45 am]
BILLING CODE 4140-01-P